State-of-the-art Radiochemicals Facility
Amersham* Radiolabelling Services was acquired by Quotient Bioresearch from GE Healthcare in June 2009.
At the time of the acquisition, Quotient formed its Chemistry & Metabolism business unit and announced a £15 million investment in a new facility in Cardiff. The dedicated facility is now fully operational and shipments of radiolabelled products have commenced. All staff have successfully transferred from the former site operated by Amersham Radiolabelling Services to the new facility; it has been named “The Old Glassworks”, reflecting the origins of the site on which it was built.
The Old Glassworks has been equipped with world-class technology, operating to the highest environmental and safety standards. It houses the largest and most experienced team of radiosynthesis chemists in the world
Read the full press release
New State-of-the-Art Radiochemistry Facility Fully Operational; First Custom “Preps” Shipped
View the video to see how the facility was planned and built 